2-(2-BENZOFURANYL)-2-IMIDAZOLINE HYDROCHLORIDE manufacturers
|
| | 2-(2-BENZOFURANYL)-2-IMIDAZOLINE HYDROCHLORIDE Basic information |
| | 2-(2-BENZOFURANYL)-2-IMIDAZOLINE HYDROCHLORIDE Chemical Properties |
| storage temp. | Desiccate at RT | | solubility | DMSO: 20mg/mL, clear | | form | White powder. | | color | White to off-white | | Water Solubility | Soluble to 100 mM in water | | InChI | 1S/C11H10N2O.ClH/c1-2-4-9-8(3-1)7-10(14-9)11-12-5-6-13-11;/h1-4,7H,5-6H2,(H,12,13);1H | | InChIKey | RFNFFVDVGWOSNZ-UHFFFAOYSA-N | | SMILES | [H]Cl.C12=CC=CC=C1OC(C3=NCCN3)=C2 |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral Eye Irrit. 2 Skin Irrit. 2 |
| | 2-(2-BENZOFURANYL)-2-IMIDAZOLINE HYDROCHLORIDE Usage And Synthesis |
| Uses | 2-(Benzofuran-2-yl)-2-imidazoline Hydrochloride is a I2 receptor agonists that induces hypothermic effect in rats. | | Biological Activity | High affinity I 2 ligand (K i = 9.8 nM). Putative I 2 agonist; potentiates morphine antinociception. Produces ipsiversive rotational behavior in rats with a full 6-OHDA lesion of the nigrostriatal tract. | | in vivo | RX 801077 hydrochloride (5, 10, 20 mg/kg; i.p.; twice daily for 3 days) inhibits NLRP3 inflammasome-induced inflammation and necroptosis in a rat model of traumatic brain injury[2]. | Animal Model: | 280-300 g, Male adult Sprague-Dawley rats (TBI model)[2] | | Dosage: | 5, 10, 20 mg/kg | | Administration: | I.p.; twice daily for 3 days | | Result: | Attenuated neurological deficits, brain edema, BBB permeability and cortical tissue loss in a rat model of TBI, reduced microglial activation, neutrophil infiltration, and proinflammatory cytokine IL-1β secretion, reduced the expression of RIP1 and RIP3 in neurons in the pericontusional cortex. |
| | storage | Desiccate at RT |
| | 2-(2-BENZOFURANYL)-2-IMIDAZOLINE HYDROCHLORIDE Preparation Products And Raw materials |
|